Spellman David A 4
4 · Mersana Therapeutics, Inc. · Filed Mar 14, 2018
Insider Transaction Report
Form 4
Spellman David A
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2018-03-12+150,000→ 150,000 totalExercise: $13.97Exp: 2021-03-12→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 25% of the shares on the first anniversary of the grant date and in equal quarterly installments over the next three years.